Back to top
more

Tenet Healthcare (THC)

(Delayed Data from NYSE)

$165.21 USD

165.21
1,128,110

-3.31 (-1.96%)

Updated Nov 8, 2024 04:00 PM ET

After-Market: $165.15 -0.06 (-0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

1-Strong Buy of 5 1        

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 11% (28 out of 250)

Industry: Medical - Hospital

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Why Is Tenet (THC) Up 6.9% Since Last Earnings Report?

by Zacks Equity Research

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Should You Retain HCA Healthcare in Your Portfolio?

by Zacks Equity Research

Gaining traction from strategic moves and a solid uptake of telehealth medicines, HCA Healthcare (HCA) holds prospects of reaping benefits for investors.

Tenet Healthcare Up 39% in a Year: Further Upside Left?

by Zacks Equity Research

Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to support its margins, which in turn, might perk up its share price.

Community Health Up 118.9% in a Year: Further Upside Left?

by Zacks Equity Research

Community Health's (CYH) strategic measures are likely to fetch revenues, which in turn, may bump up its share price.

Tenet Healthcare (THC) Q2 Earnings Beat Estimates, Rise Y/Y

by Zacks Equity Research

Tenet Healthcare's (THC) Q2 earnings gain from operational performance, partly offset by lower revenues.

Tenet Healthcare (THC) Tops Q2 Earnings Estimates

by Zacks Equity Research

Tenet (THC) delivered earnings and revenue surprises of 227.27% and -4.76%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Centene's (CNC) Q2 Earnings Miss Estimates, Revenues Beat

by Zacks Equity Research

Centene's (CNC) second-quarter results reflect robust revenues.

Tenet Healthcare (THC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Tenet (THC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Anthem (ANTM) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Anthem's (ANTM) second-quarter results are likely to reflect impressive revenues and rising membership.

What's in the Cards for Centene's (CNC) Q2 Earnings?

by Zacks Equity Research

Centene's (CNC) Q2 results are likely to reflect better revenues, partly offset by the COVID-19 impact.

ACHC vs. THC: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

ACHC vs. THC: Which Stock Is the Better Value Option?

Acadia Healthcare Opens Mental Health Unit With Tower Health

by Zacks Equity Research

Acadia Healthcare (ACHC) unveils a facility to fortify its foothold in the mental health and behavioral healthcare market.

Here's Why You Should Steer Clear of MEDNAX (MD) at Present

by Zacks Equity Research

Pressure from the COVID-19 impact on global economy and lack of solvency make MEDNAX (MD) an unattractive bet.

Are Options Traders Betting on a Big Move in Tenet Healthcare (THC) Stock?

by Zacks Equity Research

Investors need to pay close attention to Tenet Healthcare (THC) stock based on the movements in the options market lately.

Tenet Healthcare Plunges 55.7% YTD: Will the Stock Rebound?

by Zacks Equity Research

Even though Tenet Healthcare (THC) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its endeavors and strong fundamentals.

ACHC or THC: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

ACHC vs. THC: Which Stock Is the Better Value Option?

Here's Why You Should Steer Clear of HCA Healthcare Now

by Zacks Equity Research

Elevated expenses and muted revenues due to coronavirus pandemic make HCA Healthcare (HCA) an unattractive bet.

Community Health to Sell Unit for Streamlining Operations

by Zacks Equity Research

Community Health (CYH) is set to sell hospital units for debt-reduction and business rejig.

Sapna Bagaria headshot

Court Ruling on Price Transparency Unsettles Hospital Stocks

by Sapna Bagaria

Stocks of most hospital companies take a hit after the federal court retains the rules pertaining to pricing transparency.

Here's Why You Should Add Ensign Group to Your Portfolio

by Zacks Equity Research

Strategic initiatives and a healthy balance sheet make Ensign Group (ENSG) an attractive pick for investors.

MEDNAX's (MD) Strategic Initiatives to Streamline Operations

by Zacks Equity Research

MEDNAX (MD) declares several transformational activities, which augur well for the long term.

Why Is Tenet (THC) Up 17% Since Last Earnings Report?

by Zacks Equity Research

Tenet (THC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Why Should You Hold on to Tenet Healthcare (THC) Stock?

by Zacks Equity Research

Despite the recent drag in Tenet Healthcare's (THC) business volumes, the same is expected to bounce back, given its solid fundamentals and the strategic initiatives taken.

Sapna Bagaria headshot

Hospital Industry's Dull Near-Term Outllook Induced by Coronavirus

by Sapna Bagaria

Revenue loss and cost rise due to coronavirus outbreak put hospital companies in a tight spot.

Zacks.com headshot

MEDNAX Plunges More Than 42% YTD: Will the Stock Rebound?

by Zacks.com

Even though MEDNAX (MD) endures the COVID-19 impact on global economy, it holds prospects to revive its fortunes with the help of its initiatives and strong fundamentals.